Plain-English translation of NCT06863701 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether combining Etoricoxib with Betamethasone works better than Etoricoxib alone for relieving the severe pain and swelling of a sudden gout attack. Gout is a painful form of arthritis caused by uric acid buildup in your joints. Researchers want to see if the two-drug combination can reduce pain faster and more effectively over 8 days.
Gout attacks are extremely painful and people need relief quickly. This study wants to find out whether adding a second medication to this treatment works better at controlling pain and swelling than the current single-drug approach.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive one of two treatments — either the new two-drug combination or the single drug — taken as one tablet by mouth once daily for 8 days. You will visit the clinic three times: on day 0 (when you start), day 5, and day 8. During these visits, the researchers will check how much your pain has improved and watch for any side effects. If needed, you can also take acetaminophen (Tylenol) as rescue pain relief with your doctor's approval.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Mexico